n-methylaspartate has been researched along with baicalein in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Ge, QF; Hu, X; Huang, XJ; Liu, JR; Song, Y; Wang, ML; Wei, EQ; Zhang, WP | 1 |
Bai, XY; Du, GH; Fang, JS; Gao, L; Liu, AL; Wang, YT; Zhou, D | 1 |
2 other study(ies) available for n-methylaspartate and baicalein
Article | Year |
---|---|
Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation.
Topics: Analysis of Variance; Animals; Arachidonate 5-Lipoxygenase; Blotting, Western; Calcium; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Flavanones; Immunohistochemistry; Ketamine; Minocycline; N-Methylaspartate; Neuroprotective Agents; PC12 Cells; Rats; Tetrazolium Salts; Thiazoles; Time Factors | 2006 |
In silico target fishing for the potential targets and molecular mechanisms of baicalein as an antiparkinsonian agent: discovery of the protective effects on NMDA receptor-mediated neurotoxicity.
Topics: Antiparkinson Agents; Apoptosis; Binding Sites; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cell Line, Tumor; Databases, Factual; Dizocilpine Maleate; Drug Evaluation, Preclinical; Flavanones; Humans; Molecular Docking Simulation; Monoamine Oxidase; N-Methylaspartate; Neuroprotective Agents; Nitric Oxide; Protein Binding; Protein Structure, Tertiary; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate | 2013 |